Consumer Association Urges Malaysia to Ban E-cigarettes to Prevent Nicotine Addiction among Children

Sep.25.2022
Consumer Association Urges Malaysia to Ban E-cigarettes to Prevent Nicotine Addiction among Children
Consumer group urges Malaysia to ban e-cigarettes to prevent nicotine addiction among children, citing health risks and easy access.

The Consumers Association of Penang in Malaysia is urging the Ministry of Health to immediately ban all electronic cigarette products to prevent a large number of children from becoming addicted to nicotine.


According to data from the World Health Organization, electronic cigarettes contain nicotine and other toxic substances, which have a significant impact on users who are exposed to second-hand aerosols. Nicotine is a highly addictive substance and there is evidence to suggest that non-smoking minors who use e-cigarettes are twice as likely to smoke traditional cigarettes later in life.


According to research by CAP, children in Malaysia are able to easily purchase cheap electronic cigarettes because sellers do not inquire about the buyer's age. Children as young as 8 years old can purchase vaping devices and multiple children may even share one.


Mohideen Abdul Kader, a member of the Consumers Association of Penang (CAP), stated in a letter that although electronic nicotine delivery systems were only commercialized in Malaysia in early 2015, the number of people using these products in the country has increased from 600,000 in 2016 to 1.2 million in 2019. The National Treatment Centre (University of Malaya in George Town) reported approximately 30 cases of e-cigarette-related poisoning from 2015 to 2020, with most occurring in children aged 1-4 who are at high risk of death after ingesting e-cigarette liquid.


In Malaysia, the incidence of childhood cancer among children under 15 is nearly 77.4 cases per one million. Several studies have shown an increasing risk of cancer among those who use electronic cigarettes, or vaping. A study published in February 2022 found that vapers faced a higher risk of cancer than non-smokers. Evidence also suggests that US males and females aged 18 and above with a history of vaping are at a higher risk of bladder and lung cancer compared to those who have never smoked. Preclinical studies on mice exposed to e-cigarette vapors have shown increased incidence of lung adenocarcinoma and bladder urothelial hyperplasia.


Moon-shong Tang, from the New York University School of Medicine, has commented that "users of e-cigarettes, regardless of their age, have a higher risk of developing cancer than non-users". He told Lancet Oncology that in order to control childhood cancer, Malaysia should "prohibit the sale of e-cigarettes to minors".


According to Subbarow, over 20 countries have banned the sale of electronic cigarette products, and other nations including Australia, Norway and Canada have also implemented restrictions.


Malaysia's Health Minister, Khairy Jamaluddin, has proposed the "2022 Tobacco and Vaping Control Bill," which will impose fines on individuals born on or after January 1st, 2007, who sell tobacco or e-cigarette products. The bill is aimed at curbing the usage of tobacco and vaping products among younger generations.


Statement:


The content of this article has been compiled from third-party information and is intended solely for industry exchange and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the content. The compilation of this article is only intended for industry communication and research.


Due to limitations in the level of translation, the translated article may not fully reflect the original meaning. Please refer to the original text for accuracy.


2FIRSTS is fully aligned with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, and foreign issues, statements, and positions.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Italian Court Ends Six-Year Cigarette Excise Dispute, Rejecting Damages Claim
Italian Court Ends Six-Year Cigarette Excise Dispute, Rejecting Damages Claim
Italy’s Lazio Regional Administrative Court has dismissed an appeal by Italian Tobacco Manufacturing and Manifattura Italiana Tabacco over the cigarette excise calculation mechanism, upholding the minimum tax burden rules and excluding compensation for smaller tobacco operators.
News
Jun.26 by 2Firsts Perspectives
UK Vaping Products Duty to Raise £565 Million by 2030/31
UK Vaping Products Duty to Raise £565 Million by 2030/31
The UK will introduce Vaping Products Duty on all vaping liquids from October 1, 2026, with government revenue forecast to rise from £135 million in 2026/27 to £565 million by 2030/31.
Jun.18
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
PMI to Launch IQOS in Argentina by End-2026 After Regulatory Shift, Targeting About 7 Million Smokers
PMI to Launch IQOS in Argentina by End-2026 After Regulatory Shift, Targeting About 7 Million Smokers
Philip Morris International (PMI) has confirmed plans to bring its IQOS heated tobacco device to Argentina by the end of 2026, after the Argentine government lifted long-standing restrictions and created a regulatory framework for heated tobacco, e-cigarettes and nicotine pouches.
News
Jun.26 by 2Firsts Perspectives
China Tobacco Hubei Industrial Patent Discloses Nicotine Tooth Patch for Fixed Oral Delivery
China Tobacco Hubei Industrial Patent Discloses Nicotine Tooth Patch for Fixed Oral Delivery
According to Chinese patent records, a “nicotine tooth patch” application filed by China Tobacco Hubei Industrial Corporation (CTHB) and Hubei Xinye Tobacco Sheet Development Co., Ltd. was published on May 19, 2026. The filing proposes a nicotine gel patch that adheres to the tooth surface, especially the lingual side, to reduce displacement, foreign-body sensation, and accidental swallowing risks associated with existing oral nicotine products.
Jun.10
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
A smoke-free nicotine policy report argues that tobacco harm reduction should move beyond product bans and health warnings into tax policy, insurance pricing and risk-based regulation. While some projections remain open to debate, the report highlights a wider challenge: nicotine products, technologies and consumer behavior have changed sharply over the past decade, and regulatory systems may need new tools to better align tobacco control with harm-reduction goals.
Jun.08